Moneyline: PharMerica, FOSRx make buys
By HME News Staff
Updated Wed January 25, 2017
LOUISVILLE, Ky. - Amerita, the Specialty Infusion Division of PharMerica, has acquired Fairlawn, N.J.-based Nextron, a provider of certain specialty medications in the home. The move allows Amerita to further its expansion in the eastern United States.
“This expansion is consistent with our strategy to become a national home infusion provider,” said Greg Weishar, PharMerica's CEO, in a press release.
Paragon Ventures served as adviser to Nextron. Terms of the deal were not disclosed.
FOSRx closes deal
CUMBERLAND, Md. - Factor One Source Pharmacy has acquired Metairie, La.-based Fast Access Specialty Therapeutics. Together the two companies generated approximately $136 million dollars in revenue in 2016 and are projected to generate $156 million in revenue for 2017.
Sajal Roy, CEO of FOSRx, will become CEO of the combined companies.
FAST, which has 42 employees and annual revenue of nearly $100 million, will retain its brand but operate under the FOSRx umbrella.
Paragon Ventures served as adviser to Nextron. Terms of the deal were not disclosed.
Comments